KELLY ECKES: Open Payments
NPI 1932620002 · CASPER, WY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,736 in 58 payments from 10 companies in 2025. Trend: 2023 $1,680 · 2024 $1,299 · 2025 $1,736
Food & beverage: $1,736
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 18 | $383 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 21 | $375 |
| AstraZeneca Pharmaceuticals LP | 5 | $335 |
| Novo Nordisk Inc | 5 | $203 |
| Alkermes, Inc. | 3 | $183 |
| GlaxoSmithKline, LLC. | 1 | $124 |
| Neurocrine BioSciences, Inc. | 1 | $49 |
| Collegium Pharmaceutical, Inc. | 2 | $43 |
| ABBVIE INC. | 1 | $21 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
Products named: CAPLYTA, AIRSUPRA, REXULTI, Ozempic, AREXVY, ARISTADA, ABILIFY MAINTENA, LYBALVI.
Industry payments across WY — which companies pay providers there.
